Regional differences in patient (pt) characteristics of AVAGAST: An exploratory comparison in chemotherapy plus placebo (PL) arm between Japanese (JPN) and the rest of the world (ROW) pts.
Tomohira Nishina
Honoraria - Chugai Pharma
Akira Sawaki
No relevant relationships to disclose
Kensei Yamaguchi
Honoraria - Bristol-Myers Squibb; Chugai Pharma; Merck Serono
Toshihiko Doi
No relevant relationships to disclose
Yasuhide Yamada
Research Funding - Chugai Pharma
Keisho Chin
No relevant relationships to disclose
Taroh Satoh
No relevant relationships to disclose
Narikazu Boku
Honoraria - Ono Pharmaceutical ; Taiho Pharmaceutical; Takeda
Research Funding - Taiho Pharmaceutical
Yasushi Omuro
No relevant relationships to disclose
Yoshito Komatsu
No relevant relationships to disclose
Hiroya Takiuchi
Honoraria - Chugai Pharma
Research Funding - Chugai Pharma
Yasuo Hamamoto
No relevant relationships to disclose
Wasaburo Koizumi
No relevant relationships to disclose
Shigehira Saji
No relevant relationships to disclose
Manish A. Shah
Consultant or Advisory Role - Genentech
Eric Van Cutsem
Research Funding - Roche
Yoon-Koo Kang
Consultant or Advisory Role - Roche
Honoraria - Roche
Atsushi Ohtsu
Honoraria - Chugai Pharma; Novartis; Taiho Pharmaceutical